<DOC>
	<DOCNO>NCT01117025</DOCNO>
	<brief_summary>The purpose study comparative evaluation systolic blood pressure ( SBP ) lowering , atrial fibrillation ( AF ) recurrence clinical data patient paroxysmal/persistent AF resistant hypertension , undergo AF ablation alone combine percutaneous renal denervation .</brief_summary>
	<brief_title>Combined Treatment Resistant Hypertension Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Coronary Vasospasm</mesh_term>
	<criteria>Symptomatic drugrefractory AF ( history failure ≥2 class I III antiarrhythmic drug ) patient refer catheter ablation AF PAF ≥1 monthly episode PersAF patient already undergone ≥3 electrical cardioversions . PAF define episode last less 7 day spontaneous termination . PersAF define last 7 day terminate pharmacologically electrical cardioversion . Officebased systolic blood pressure ≥160 mm Hg , despite treatment ≥3 antihypertensive drug ( include 1 diuretic ) A glomerular filtration rate ≥45 mL/min/1⋅73 m2 , modification diet use renal disease formula Previous atrial fibrillation ablation Type 1 diabetes mellitus Structural heart disease Secondary cause atrial hypertension Severe renal artery stenosis renal artery abnormalities Previous operation renal artery Pregnancy Previous heart , kidney , liver , lung transplantation Unwillingness participant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Resistant hypertension</keyword>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Percutaneous renal denervation</keyword>
</DOC>